Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier

Author:
  • Oskar T Johannsson
  • Synnöve Staff
  • Johan Vallon-Christersson
  • Soili Kytöla
  • Thorarinn Gudjonsson
  • Karin Rennstam
  • Ingrid A Hedenfalk
  • Adewale Adeyinka
  • Elisabeth Kjellén
  • Johan Wennerberg
  • Bo Baldetorp
  • Ole W Petersen
  • Håkan Olsson
  • Stina Oredsson
  • Jorma Isola
  • Ake Borg
Publishing year: 2003-03
Language: English
Pages: 96-387
Publication/Series: Laboratory Investigation
Volume: 83
Issue: 3
Document type: Journal article
Publisher: Nature Publishing Group

Abstract english

A human tumor xenograft (L56Br-X1) was established from a breast cancer axillary lymph node metastasis of a 53-year-old woman with a BRCA1 germ-line nonsense mutation (1806C>T; Q563X), and a cell line (L56Br-C1) was subsequently derived from the xenograft. The xenograft carries only the mutant BRCA1 allele and expresses mutant BRCA1 mRNA but no BRCA1 protein as determined by immunoprecipitation or Western blotting. The primary tumor, lymph node metastasis, and xenograft were hypodiploid by DNA flow cytometry, whereas the cell line displayed an aneuploidy apparently developed via polyploidization. Cytogenetic analysis, spectral karyotyping, and comparative genomic hybridization of the cell line revealed a highly complex karyotype with numerous unbalanced translocations. The xenograft and cell line had retained a somatic TP53 missense mutation (S215I) originating from the primary tumors, as well as a lack of immunohistochemically detectable expression of steroid hormone receptors, epidermal growth factor receptor, human epidermal growth factor receptor 2 (HER-2), and keratin 8. Global gene expression analysis by cDNA microarrays supported a correlation between the expression profiles of the primary tumor, lymph node metastasis, xenograft, and cell line. We conclude that L56Br-X1 and L56Br-C1 are useful model systems for studies of the pathogenesis and new therapeutic modalities of BRCA1-induced human breast cancer.

Keywords

  • Otorhinolaryngology
  • Cancer and Oncology
  • Aneuploidy
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Codon, Nonsense
  • DNA, Neoplasm
  • Female
  • Flow Cytometry
  • Genes, BRCA1
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Lymph Nodes
  • Lymphatic Metastasis
  • Middle Aged
  • Nucleic Acid Hybridization
  • Spectral Karyotyping
  • Translocation, Genetic
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Other

Published
  • Head and Neck Cancer Research Group
  • Lund Melanoma Study Group
  • ISSN: 1530-0307
Stina Oredsson
E-mail: stina [dot] oredsson [at] biol [dot] lu [dot] se

Professor

Functional zoology

+46 46 222 94 97

B-C208

4

Principal investigator

LUCC - Lund University Cancer Centre

Research group

Animal Physiology

Projects

Cell proliferation

Doctoral students and postdocs

PhD Students, main supervisor

Wendy Soria Sotillo

PhD Students, assistant supervisor

Atena Malakpour Permlid